NZMP: New Research Hopes to Unlock Understanding of How the Gut and Brain...
LONDON NZMP SureStart™, the global B2B paediatric ingredients brand of Fonterra, announces today it is part of Smarter Lives, a five-year research programme to investigate how nutrition impacts the...
View ArticlePacific Prime Receives Bupa Global’s Best Performance – Intermediary Award
HONG KONG Pacific Prime is pleased to announce that they have been honored with the ‘Best Performance Award – Intermediary’ from Bupa Global at their annual APAC conference. Held annually, this...
View ArticleCANbridge Receives Approval to Commence CAN008 Phase II/III Trial in...
BEIJING, China CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, announced that the China Food and Drug Administration...
View Articleハートサイエンシズが臨床試験結果のJournal of the American College of Cardiology(JACC)への掲載を発表
米テキサス州サウスレイク (ビジネスワイヤ) —...
View ArticleRECELL® Study in Facial Burns Shows Excellent Cosmetic Outcomes
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today results from a clinical study highlighting the potential benefits of the RECELL® Autologous Cell...
View ArticlePatient Safety Movement Foundation Supports the Tokyo Declaration on Patient...
IRVINE, Calif. The Patient Safety Movement Foundation (PSMF) announced its support for the Tokyo Declaration on Patient Safety, which was put forward by Japan, Germany, and the United Kingdom at the...
View ArticleRECELL® Pivotal Trial in Third-Degree Burns Meets Co-Primary Endpoints and...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that its pivotal, controlled clinical trial in the treatment of deep full-thickness (third-degree)...
View ArticleMaxiNovel Disclosed the Study Results of Orally Active PD-1/PD-L1 Inhibitors...
GUANGZHOU, China MaxiNovel Pharmaceuticals, Inc. presented for the first time the preclinical results of its orally active PD-1/PD-L1 inhibitors either as a single agent or in combo studies. The key...
View Article患者安全运动基金会支持《患者安全东京宣言》
加州尔湾 (美国商业资讯) — 患者安全运动基金会(PSMF)宣布支持《患者安全东京宣言》,该宣言由日本、德国和英国在2018年4月13-14日于日本东京召开的第三届全球患者安全部长级峰会上提出。该宣言敦促各国加快迈向增进全球患者安全的进程,方法是通过步调一致的激励机制、增加透明度、落实各项惯例,这些惯例认可医疗保健安全和品质不断改进的重要性。 本新闻稿包含多媒体。此处查看新闻稿全文:...
View ArticleShionogi to Present New Data at 2018 European Congress of Clinical...
OSAKA, Japan Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced that the company will give 13 presentations on investigational agents at the upcoming European Congress of Clinical...
View ArticleKansai Paint Group Announces First Ever Anti-Mosquito Paint Approved By the EPA
TROY, Mich. Kansai Paint Group, a global manufacturer of paints and coatings, (Head office: Osaka Japan, President and CEO: Hiroshi Ishino) has announced approval from the U.S. Environmental...
View Article全球顶尖高科技领军人物将于5月11日在旧金山举行的百万美元创业世界杯总决赛上发言
加州圣何塞 (美国商业资讯) –创业世界杯(Startup World Cup)今天宣布了2018年创业世界杯全球总决赛(Global Grand Finale)的演讲嘉宾和评委名单,决赛将于2018年5月11日在旧金山的马奎斯万豪酒店(Marriott...
View Articleサンフランシスコで5月11日に開催される賞金100万ドルのコンテスト「スタートアップワールドカップ」に世界トップの技術リーダーが参加
米カリフォルニア州サンノゼ (ビジネスワイヤ) —...
View ArticleVaxart Announces $5 Million Inavir® Revenue Milestone
SOUTH SAN FRANCISCO, Calif. Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced today that...
View Article新研究调查Masimo SpHb®在术后红细胞(RBC)输血最佳实践中的功用
葡萄牙里斯本 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了患者血象管理、止血和栓塞促进网络(NATA) 2018年度年会上呈报的一份摘要中的发现,该研究的研究人员调查了Masimo无创连续血红蛋白(SpHb®)作为术后患者血象管理(PBM)的一部分在支持和提升红细胞(RBC)输血最佳实践中的功用1。 本新闻稿包含多媒体。此处查看新闻稿全文:...
View ArticleOMRON’s Fiscal 2017 Net Income Jumps 37.3%, to Record JPY63.2 Billion
KYOTO, Japan OMRON Corporation (TOKYO:6645) today announced its consolidated operating results for fiscal 2017, ended March 31, 2018. Companywide growth in the core Industrial Automation and...
View Article